UPDATE: Pfizer Shares Higher After Finding Statistically Significant Reduction Related to NONACOG ALFA

By: via Benzinga
Pfizer Inc. (NYSE: PFE) today announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX® Coagulation ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.